| Sources | Names Used |
|---|---|
| CTRPv2 | compound 1B |
| PharmacoGx | compound 1B |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IMP4 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | TAS2R46 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | POP5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | RAP1B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TMEM214 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | DNTTIP1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | ZNF688 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | HLTF | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | WDR92 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
